• Catalá

• Castellano

• English

• INTRANET

• WEBMAIL

VHIO is a leading comprehensive cancer center

of excellence where its scientists and physicians adopt

a purely translational research model, working together

as multidisciplinary teams to both accelerate

and advance personalized and

targeted therapies against cancer:

• DISCOVER MORE

Scientific activity at VHIO is structured across for major programs: Preclinical, Translational, Clinical Research, and Core Technologies. Each incorporates research teams of excellence dedicated to harnessing

and rapidly translating discoveries

into tangible benefits for patients.

• MEET VHIO´S TEAMS

Research at VHIO is led by our Director, Josep Tabernero, and supported

by a consultative body, VHIO´s Scientific Committee headed by

José Baselga. A total of 20 renowned Principal Investigators manage

and run VHIO´s major research themes and programs.

• BROWSE OUR PIs

Driving drug development & targeted therapies against cancer, VHIO has become a leading reference in drug discovery from concept 

to clinic:

• CLINICAL TRIALS OFFICE 
• RESEARCH UNIT FOR MOLECULAR THERAPY OF CANCER - "LA CAIXA"

Research at VHIO is made possible through the support received from private institutions, funding entities, companies and individuals, as well as International and National Competitive Grants. Find out more about our supporters, current projects and VHIO´s Scientific Coordination Area:

• CURRENT PROJECTS 
• SCIENTIFIC COORDINATION

VHIO organizes international symposia of excellence as well as ad-hoc courses and workshops through which it shares its expertise and promotes debate and exchange of the highest degree:

• VHIO SPECIAL SYMPOSIUM: Towards Predictive Cancer Models, 26 – 27 May 2016
  
• WORKSHOPS & COURSES